USX:BNR - Burning Rock Biotech Limited BURNING ROCK BIOTECH LTD-ADR
Sector: Health Care, Industry: Life Sciences Tools & Services
Add to Watchlist
   
Add Alert 


Yahoo Finance

USD 27.22    -1.150 (-4.05%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

18 Jun 2021


Loading...
Loading...
Loading...

General

CEO: Dr. Shaokun Chuai

IPO: 2020-06-12

Headquarters: US

Employees: 938

Homepage

Description

Burning Rock Biotech Ltd is a cancer diagnostics company. Its products include OncoScreen Plus and ColonCore. The company has developed various cancer detection products, involving tumor targeting, differentiation of benign and malignant tumors, monitoring of small residual lesions, prediction of tumor recurrence progress, and detection of tumor sensitivity. It offers 12 NGS-based cancer therapy selection tests comprising a broad range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer, using both tissue and liquid biopsy samples.